June 2022 Florida Pharmacy Today by Florida Pharmacy Today

JUNE 2022

FLORIDA OPIOID SETTLEMENTS AND THE ALLOCATION OF SETTLEMENT FUNDS

24/7 coverage lets you focus on patients, not potential mistakes.

PROFESSIONAL LIABILITY COVERAGE COMPARISON PHARMACIST MUTUAL INSURANCE COMPANY

COMPETITOR

Pharmacists Professional Liability

$1MM per occurrence / $3MM aggregate $2MM per occurrence / $4MM aggregate

$1MM per occurrence / $3MM aggregate

Sterile Compounding

Available

Pharmacists License Defense Coverage

$250,000 per occurrence / $250,000 aggregate

$25,000

Board of Pharmacy Imposed Fees

$2,500 sublimit

HIPAA Claim Defense Coverage

$50,000

$25,000

Assault Coverage

$25,000

Sexual and Physical Abuse Coverage

$50,000

$25,000 sublimit

$1,500 per day / $50,000 per occurrence

1,000 per day / $25,000 aggregate

$50,000 limit

$10,000 aggregate

Loss of Income Legal fees – Respond to Subpoena

Professional | Commercial | Personal | Life & Disability

phmic.com Policy terms and conditions control. Coverage may not be available in all states. Life and disability insurance are written through PMC Advantage Insurance Services, Inc., a wholly-owned subsidiary of Pharmacists Mutual Insurance Company.

WHAT IF you were named in a lawsuit and needed a lawyer?

WHAT IF your employer does not have the coverage to protect you?

WHAT IF you have a second job, volunteer, or give advice to a friend or neighbor?

florida PHARMACY TODAY Departments 4 Calendar 4 Advertisers 5 Executive Insight

VOL. 85 | NO. 6 JUNE 2022 THE OFFICIAL PUBLICATION OF THE FLORIDA PHARMACY ASSOCIATION

Features

The Invisible War

Florida Opioid Settlements and the Allocation of Settlement Funds

132 Annual Meeting and Convention of the Florida Pharmacy Association

FPA Board of Directors

Daniel Buffington......................................... President and Interim Board Chair Carol Motycka...................................................................................President Elect Elias Chahine................................................................................... FSHP President Alexander Pytlarz.................................................................Speaker of the House Verender Brown........................................................................Technician Director William Mincy............................................................................................ Treasurer TBD......................................................................................................... Vice Speaker Joyanna Wright.............................................................................Region 1 Director Tejas Patel.......................................................................................Region 2 Director Matt Schneller..............................................................Region 3 Director (Interim) Cheryl Rouse.................................................................................Region 4 Director Bob Parrado...................................................................................Region 5 Director Katherine Petsos...........................................................................Region 6 Director Paul Delisser..................................................................................Region 7 Director Carmen Aceves Gordon..............................................................Region 8 Director Goar Alvarez.................................................................................Region 9 Director Michael Jackson......................................................................................EVP & CEO JUNE 2022

FPA Calendar 2022

JULY

SEPTEMBER

Independence Day, FPA Office Closed

Deadline for Officer and Director Nominations

6-10

132nd Annual Meeting and Convention Ft. Lauderdale

10-11

FPA Clinical Conference via Zoom

39th Annual SE Gatherin Destin

1-4

NCPA Annual Meeting, Kansas City

FPA Point of Care Test & Treat training program Kissimmee, Florida

8-9

FPA Midyear Clinical Kissimmee, Florida

31-3

OCTOBER

AUGUST 20

FPA Budget and Finance and Council Meetings - Orlando, Florida

FPA Board of Director Meeting Orlando, Florida

FPA Board of Directors Meeting

24-25

Board of Pharmacy Meeting (pending Approval)

CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours’ LIVE continuing education as part of the required 30 hours’ general education needed every license renewal period. There is a two-hour CE requirement for pharmacists on the dispensing of controlled substances effective this biennial renewal period. The Reducing Medication Errors course is needed for pharmacists and technicians. Pharmacists should have satisfied all continuing education requirements for this biennial period by Sept. 30, 2023, or prior to licensure renewal. Consultant pharmacists and technicians will need to renew their licenses and registrations by Dec. 31, 2022. For the Pharmacy Technician Certification Board application, exam information and study materials, please contact the FPA office. For more information on CE programs or events, please contact the Florida Pharmacy Association at (850) 222-2400 or visit our website at www.floridapharmacy.org CONTACTS FPA — Tian Merren-Owens (850) 222-2400 FSHP — Tamekia Bennett (850) 906-9333 UF — Emely McKitrick (352) 273-5169

FAMU — Dr. Selika Sampson (850) 599-3301

Note: The views of the authors do not necessarily represent the views or opinions of the Florida Pharmacy Association, Florida Pharmacy Today or any related entities.

Mission Statements: Florida Pharmacy Today Journal The Florida Pharmacy Today Journal is a peer-reviewed journal which serves as a medium through which the Florida Pharmacy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.

Florida Pharmacy Today Board of Directors The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and executive editor of the Florida Pharmacy Today Journal in the establishment and interpretation of the Journal’s policies and the management of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the Journal in its goal of self-support.

Advertisers APMS................................................................... 19 PQC...................................................................... 20 PHARMACISTS MUTUAL................................ 2

NSU — Carsten Evans (954) 262-1300

DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association is engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.

4 |

FLORIDA PHARMACY TODAY

EMAIL YOUR SUGGESTIONS/IDEAS TO dave@fiorecommunications.com

Executive Insight MICHAEL JACKSON, BPHARM, RETIRED EVP & CEO, FLORIDA PHARMACY ASSOCIATION

New FPA Networking Opportunity

he profession of pharmacy is highly diversified with licensed and registered practitioners serving patients is many different types of health care fields. Historicatlly, one may think of pharmacy in two distinct buckets. The terms community pharmacist and institutional pharmacists are no longer exclusive in our industry. With our pharmacy degrees and licenses, we have the ability to engage in well over 80 different aspects of health care services. With these numerous career options comes a desire to find a way to network our members with others who have a common interest. In 1984, the Florida Pharmacy Association established the Academy of Pharmacy Practice (APP) as part of the general restructuring of the association. The APP was created in order to allow pharmacists (and friends of pharmacy) who share a common practice setting and/or professional interest the opportunity to influence the scope and direction of their professional careers in a forum which enables them to exchange ideas, identify and seek resolution to issues of concern. This entity within the FPA was ideal for gathering those members who have common interests to exchange emerging ideas and concepts. The goal was to assist our members in becoming successful through collaboration, education and peer advocacy. Within the academy were created sections that were actually focus groups. For example, we had onboard sections of the Academy of Pharmacy Practice related to compounding, administration, institutional pharmacy practice, nuclear pharmacy, indepen-

dent pharmacy practice and even a section for employee pharmacists, technicians and more. Each section of the academy had its own governing documents and existed under the umbrella of the Florida Pharmacy Association. There was even a dedicated annual meeting of the Academy of Pharmacy Practice with plenary sessions tied to the various practice models. As with all innovative ideas and concepts, time, resources and the administrative effort needed to sustain the academy proved challenging for the association to sustain and eventually the program ended its run within the FPA. As we fast forward to the past couple of years, your association has been busy revisiting the academy concept and has found renewed interest in bringing it back to our members. The FPA House of Delegates has reinserted the Academy of Pharmacy Practice into our bylaws and a set of governing documents on the new Independent Pharmacy Practice Section has been created. The objectives of the Independent Pharmacy Practice Section state that it shall exist for the purpose of uniting all Florida registered pharmacists who provide pharmacy services within independent pharmacy practices and who share in the goals and objectives of the section such as, but not limited to, the following: A. To establish a forum in order to discuss pertinent practice issues, exchange ideas and provide a means for seeking resolutions to identified problems, needs and concerns; B. To serve as role models for other elements within pharmacy which contribute to the overall improved

Michael Jackson, B.Pharm, CPh FPA CEO (Ret)

delivery of existing professional services and to develop new avenues for the delivery of patient and professional services and to ensure patient outcomes; C. To provide a voice in the design and implementation of educational programming, policy development and legislative initiatives that benefit this element of pharmacy practice; D. To support and encourage the highest standards of individual professional services and among pharmacists. Membership in this section is open to any current FPA member in good standing who is actively engaged in or supports the interests of independent pharmacy practice. The initial officers of the new Independent Pharmacy Practice Section are being appointed and installed by President Dan Buffington at the FPA convention on Sunday, JUNE 2022

FPA STAFF Director of Continuing Education Tian Merren-Owens, ext. 120

Continuing Education Coordinator Stacey Brooks, ext. 210 Coordinator of Membership Ranada Howard, ext. 110

FLORIDA PHARMACY TODAY BOARD Chair....................David Mackarey, Boynton Beach Vice Chair................................... Matt Schneller, Tampa Treasurer.................................... Eric Jakab, Gainesville Secretary............................. Julie Burger, Pensacola Member.........................Michael Finnick, Jacksonville Member....................... Carol Motycka, Jacksonville Member............................Teresa Tomerlin, Rockledge Member...................................... Greta Pelegrin, Hialeah Technician Member..........Julie Burger, Pensacola Executive Editor.......Michael Jackson, Tallahassee Managing Editor...................Dave Fiore, Tallahassee Journal Reviewer........................... Dr. Melissa Ruble Journal Reviewer....................................Dr. Angela Hill This is a peer-reviewed publication. . ©2022 FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board.

July 10, 2022. Subsequent officers will be elected by mail ballot and will be installed next year at the FPA Convention in Marco Island, Florida. There are dues that are required for this section membership. For more information, you are welcome to visit the FPA website at https://www.floridapharmacy.org/members/group. aspx?id=240294 or you can call the FPA office and talk with a staff member. We are excited about reengaging the Academy of Pharmacy Practice.

We know that there are others within our membership that may be interested in a section. That request can be routed through the FPA’s Board of Directors who will guide you on how to start a section. It is clear that the Academy of Pharmacy Practice as a member service of the FPA seeks to enhance our desire to advocate for a unified voice and grow our efforts on policy development. Remember that if you want to go fast, go alone. If you want to go far, go together. n

OVER 90% of donations collected support political campaigns or committees! Decisions and laws are made as to how you will practice your profession of pharmacy, care for your patients, as well as how health care costs affect state budgets. Your vote and personal contributions have a direct impact on these elected officials who represent you and make decisions affecting the future of your profession. The Florida Pharmacist Political Committee (FPPC) is a means for us all to pool our resources and have a greater reach to candidates who have or will have an understanding of what's best for the practice of pharmacy and each aspect of patient care. The vast majority of your contributions go directly to political candidates to support their campaigns. The Florida Legislature typically reviews a number of pharmacy issues that affect not only our businesses but also how we practice the profession. The advocacy efforts of the Florida Pharmacy Association supported by your contributions to the FPPC will helped to ward off onerous public policy designed to put you out of business or compromise the relationships that you have with your patients.

OR SCAN THIS CODE: FLORIDA PHARMACY ASSOCIATION

610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web address: www.floridapharmacy.org.

CLICK HERE FOR SECURE ONLINE DONATION FORM

The Invisible War William Garst, Pharm.D., Consultant Pharmacist

William Garst, Pharm.D. Consultant Pharmacist

There is an invisible war being fought at the microscopic level between bacteria and fungi. We should be glad of this because these microorganisms produce chemicals that inhibit each other, and we can use these chemicals to produce antimicrobials. Bacteria will produce antifungal and antibacterial chemicals, with the fungi doing the same. They do this to compete for the nutrients in nature. What scientists try to determine are the specific antimicrobial compounds, what kind of microorganisms they inhibit, are they safe for humans, and can they be produced in large enough quantities to be cost effective. In the Philippines in 1949, scientist Abelardo B. Aguilar who was employed by Eli Lilly, collected soil into jars and labeled each with the date, location and his initials. He then carefully packed them for shipment to the U.S., specifically Indianapolis, Indiana, home of Eli Lilly Pharmaceutical Co. When the jars arrived at the company, each one’s contents were put into separate containers holding a broth designed to grow microorganisms. After a few days of incubating in the large containers, the samples of the liquid contents were put on petri dishes (dishes used to grow microorganisms in laboratories) in which a variety of bacteria were introduced. One of the petri dishes showed streaks of no bacteria growth where the liquid from the large containers was applied. This is the first indication that a substance to inhibit bacteria may be in the soil samples. The organism that produced the antibacterial compound was a bacterium called Streptomyces erythraeus later called Saccharopolyspora erythraea. The antibacterial compound was named erythromycin after the organism from which it was extracted. Erythromycin was discovered at a convenient time. Penicillin had been used for a few years by 1949 and there were beginning signs of allergic reactions and resistance showing up in people who had previously received penicillin. Erythromycin worked against many of the same bacteria that penicillin was effective against and therefore could be used as an alternative. There are a variety of dosage forms for erythromycin: oral, topical ointments, ophthalmic products, and intravenous solutions. Though it can be given orally, it is not very stable in the acidic stomach and can produce hypermotility of the gastrointestinal tract. This bothersome side effect can be taken advantage of by giving this drug to people who have

a condition called gastroparesis, a slowing down of the gastrointestinal tract. Erythromycin given at low doses can cause the gastrointestinal tract to move again, giving relief to this condition, however, this use is discouraged because bacterial drug resistance is a possible consequence. Because of the instability of erythromycin in stomach acid, another similar antibiotic drug was developed by Taisho Pharmaceutical Co. of Tokyo, Japan in the 1970s and marketed in the 1980s. This drug is clarithromycin (Biaxin) which has the same antibacterial spectrum as erythromycin but is more stable in stomach acid. In addition, it stays in the body longer and can be given fewer times a day. In the 1980s, a pharmaceutical company in Zagreb, Croatia, the Pliva Co., a subsidiary of Teva Pharmaceutical Co. of Israel, discovered azithromycin. It was brought to the U.S. market by the Pfizer Co. as Zithromax. Azithromycin is another antibiotic and is given once a day because it stays in the body an extra-long time. Azithromycin is the drug in the famous Z-Pack. The Z-Pack is a dosing regimen of azithromycin in which a person takes two 250mg tablets on day one, then one 250mg tablet daily for four more days. This regimen has been highly effective in treating respiratory infections. The development of antibiotics involves the invisible war amongst microorganisms and is a true international story with research conducted by people all over the world. Stay informed and stay healthy. William Garst is a consultant pharmacist who resides in Alachua, Florida. He received his bachelor’s degree in pharmacy from Auburn University in 1975. He earned a master’s degree in pharmacy from the University of Florida in 2001. In 2007, he received his doctor of pharmacy from the University of Colorado. Dr. Garst is a member of many national professional associations as well as the local Alachua County Association of Pharmacists. He serves on the Alachua County Health Care Advisory Board. He works part-time at the UF Health Psychiatric Hospital and retired from the VA in 2016. Dr. Garst enjoys golf, reading (especially history) and family. He writes a blog called The Pharmacy Newsletter (https://thepharmacy newsletter. com). He can be contacted at communitypharmacynewsletter@gmail.com .

JUNE 2022 |

Florida Opioid Settlements and the Allocation of Settlement Funds By TJ Morton, FPA General Counsel

From 1999 to 2019, nearly half a million Americans died from an opioid overdose.1 From 1999 until approximately 2016, more opioid overdose deaths were attributed to prescription opioids than to heroin or illicitly manufactured synthetic opioids.2 In response to this epidemic, many states and local governments filed lawsuits against various entities in the pharmaceutical supTJ Morton ply chain. As of early 2022, several states’ attorneys general, including Florida’s Attorney General, obtained settlements with major drug manufacturers and distributors. The settlements provide for substantial funds to be used by state and local governments for the abatement of the opioid epidemic. This article addresses the Florida settlements and the allocation of the settlement funds. In May 2018, the Florida Attorney General sued five drug manufacturers, and four drug distributors, for their roles in 8 |

FLORIDA PHARMACY TODAY

the creation of the opioid epidemic. The lawsuit was later amended to include an additional drug manufacturer, and the two largest retail pharmacy chains in the United States, both of which also operate as drug distributors. The lawsuit alleges the defendants engaged in deceptive and unfair trade practices, violated Florida’s RICO Act, committed a public nuisance, and, as to the distributors, acted negligently in the distribution of opioids. By May 2022, all of the defendants, with the exception of three drug manufacturers, had reached settlements with the Attorney General.3 The settlements provide funds to be paid to Florida state and local governments over a period of 18 years for the abatement of the opioid epidemic. In total, that state of Florida and its local governments could receive more than $3 billion from the defendants.4 The settlement funds are to be allocated among the state, counties, and municipalities in accordance with a Memorandum of Understanding (MOU)5 and the Opioid Allocation

and Statewide Response Agreement (OASRA)6. Only counties and municipalities that sign the MOU and OASRA may receive settlement funds. In exchange for receiving settlement funds, counties and municipalities must agree to release the defendants from any lawsuits that cover the actions addressed in the Florida Attorney General’s lawsuit. Under the MOU and OASRA, all settlement funds will initially go to the state and then, after deducting the costs for expenses such as attorneys’ fees, be distributed pursuant to the following distribution scheme: 1. 15% to the City/County Fund 2. 35% - 47% to the Regional Fund7 3. Remainder to the State Fund The percentage of funds each participating city or county will receive from the City/County Fund is based on metrics set forth in a 2019 national prescription opiate litigation case.8 The percentage of funds distributed to the Regional Fund varies based on a sliding scale. The Regional Fund receives 47% in years one through six, 41% in years seven through nine, 40% in years 10 through 12, 39% in years 13 through 15, and 35% in all subsequent years. Funds in the Regional Fund will be distributed for the benefit of counties. Funds for “qualified counties” will be paid directly to the county. A county is a “qualified county” if it (a) has a population of at least 300,000; (b) has an opioid task force; (c) has an opioid abatement plan; (d) provides substance abuse services to its citizens; and (e) enters into an agreement with the majority of municipalities related to the expenditure of the settlement funds. Funds for all other counties will be paid through the Department of Children and Family Services to entities under contract with the Department to manage the daily operational delivery of behavioral health services. Other than funds paid for expenses such as attorneys’ fees, all settlement funds must be used for an “approved purpose”. An “approved purpose” is a strategy, programming, or service to (a) develop, promote, and provide evidence-based substance use prevention strategies; (b) provide substance use avoidance and awareness education; (c) decrease the oversupply of licit and illicit opioids; or (d) support recovery from addiction.9 The MOU and OASRA also direct the establishment of an Opioid Abatement Taskforce or Council. The Taskforce will advise the Governor, legislature, Department of Children and Family Services, and local governments on abatement priorities, and review how the settlement funds have been spent and the results that have been achieved. The Taskforce will consist of 10 members, five of which represent local governments and five of which represent the state. The Florida League of Cities and Florida Association of Counties will appoint the local government members. The Governor, Speaker of the House, Senate President, and Attorney General will appoint the state representatives. The OASRA imposes certain program requirements on governments providing services pursuant to a contract or grant of settlement funds. Of note, the government must set performance measures for the provider, receive and

report expenditures, service utilization data, demographic information, and national outcome measures, and implement a monitoring process that will demonstrate oversight and corrective action in the case of non-compliance for all providers that receive settlement funds. The billions of dollars to be paid to Florida state and local governments provides a significant opportunity for pharmacists and pharmacies to assist in abating the opioid epidemic that has plagued the country for the last 20 years. Pharmacists who are interested in providing opioid abatement services should contact the relevant local governments and/or the Department of Children and Family Services to obtain information on the process for submitting a proposal. Additional information regarding the settlements can be found at the Florida Attorney General’s Opioid Settlements Portal.10 References

1. https://www.cdc.gov/drugoverdose/epidemic/index.html 2. Id. 3. Three drug manufacturers filed for bankruptcy protection. The bankruptcy filings stay the lawsuit against each ofthe defendants. 4. Florida could receive up to $1.5 billion from three major distributors; up to $744 million from the other manufacturers who have not filed for bankruptcy protection; up to $480 million from one major pharmacy chain; and up to $620 million from a second pharmacy chain. 5. Available at: https://nationalopioidsettlement.com/wpcontent/uploads/2021/08/Florida-Proposed-MOU.pdf 6. Available at: https://www.dropbox.com/s/0f69chz6u7vey9h/ FL%20Opioids%20Allocation%20%2BSW%20Resp%20 Agreement %20with%20Exhibits.pdf?dl=0 7. During the 2022 legislative session, the Florida Legislature passed HB 5013 to create the Opioid Settlement Clearing Trust Fund for the deposit and distribution of funds received from the opioid settlements. HB 5013 increased the Regional Fund percentages from 30% - 40% to 35% - 47%. HB 5013 has not yet been sent to the Governor for approval. 8. The distribution percentages for participating cities and counties are available at: https://nationalopioidsettlement. com/wp-content/uploads/2021/11/EXHIBIT-C.pdf. 9. A non-comprehensive list of approved uses is available at: https://nationalopioidsettlement.com/wpcontent/ uploads/2021/11/EXHIBIT-A.pdf & https:// nationalopioidsettlement.com/wpcontent/uploads/2021/11/ EXHIBIT-B.pdf. 10. Available at: https://app.smartsheet.com/b/publish?EQBCT= 415e64f86a0c4df39302ed3f371915d9

JUNE 2022

HELP SPONSOR-A-STUDENT

Florida Pharmacy Association (FPA) 132ND Annual Meeting & Convention July 6-10, 2022 Marriott Harbor Beach Resort & Spa – Ft. Lauderdale, Florida Again this year, students from Florida Colleges of Pharmacy are invited to attend the FPA Annual Convention. Pharmacy students will benefit from the interaction with practicing pharmacists, learn first hand how FPA actually operates and how they can become involved in their chosen profession. As you remember, college students are on a tight budget and most of them cannot afford to attend convention. Here is how you can help! Be A Student Sponsor! Student registration is only $150 and includes educational programs designed specifically for pharmacy students, House of Delegates, Exhibit Hall, FPPC Reception, University Receptions, and the Pharmacist-Student Mentor Social. Although students have their own track, they may also attend the pharmacist courses as well. You also have the option to donate any amount you prefer to help offset the overall costs associated with student events. FPA’s programs and services are keys to success in advocating for the profession, supporting pharmacy students and promoting quality patient care services. Thank you for giving back to your profession. Select a sponsor from any pharmacy school yourself, ask your local unit association or get together with friends to Sponsor-A-Student. Remember…..these are the future leaders of pharmacy! Sponsors will be listed in the convention program. Mentor Program. Each student will be assigned a pharmacist who may invite them to attend meetings, CE programs, and share their knowledge and pharmacy experience with them. If you plan to attend the convention and would like to be a mentor, please contact the FPA office. Please contact the FPA Office to sponsor a student or be a mentor. Or, complete the form below and fax or mail with your check to: Florida Pharmacy Foundation 610 North Adams Street Tallahassee, FL 32301 Fax: (850) 561-6758 Please make your check payable to the Florida Pharmacy Association Sponsor Name: ___________________________________________________________________________ Student Name: _______________________________________ College of Pharmacy___________________ Address: ________________________________________________________________________________ City: _______________________________________ State: ____________ Zip: _______________________ Phone: _____________________________________ Amount of Contribution: ________________________ Charge to the following:

 AMEX

 DISCOVER

 MASTERCARD

 VISA

Account # :_____________________________________Security Code: _________ Exp. Date: ___________ Signature: _______________________________________________________________________________  Yes, I would like to serve as a Mentor  Contact me with more information on Mentoring. 10

FLORIDA PHARMACY TODAY

132nd Annual Meeting and Convention Schedule July 6 – 10, 2022 Marriott Harbor Beach Resort & Spa 3030 Holiday Drive Ft. Lauderdale, FL JUNE 2022 |

Keynote Speaker

Theresa Tolle, BPharm, FAPhA, is owner of Bay Street Pharmacy in Sebastian, Florida for the past 25 years. Prior to owning an independent pharmacy, she had practice experience in chain, long term care (consultant) pharmacy and hospital. Her pharmacy focuses on patient services such as immunizations and testing, compounding, MTM and pharmacogenomics. Her professional activities have spanned local, state and national pharmacy associations including serving as President of Florida Pharmacy Association (2003), Treasurer of the Florida Pharmacy Political Committee (2009-present), APhA Board Member from 2014-17, 2018-21 and now President-Elect of APhA. Additional professional involvement includes serving as the Lead Luminary of CPESN Florida, a clinically integrated network of independent pharmacies within Florida. She also serves on many other national pharmacy committees and advisory boards. In her community she has served on the Board of her local Chamber of Commerce for over 14 years and chairs the Board of Trustees for her local community hospital, Sebastian River Medical Center. She also serves on Substance Abuse Free Indian River (SAFIR). Tolle is a Florida native, raised in the Florida panhandle and she graduated from University of Florida College of Pharmacy in 1988. She has won several professional awards including Bowl of Hygeia, FPA Pharmacist of the Year, APhA Good Government Award and APhA Pharmacy Management Excellence Award, Cardinal Health Ken Wurster Community Leadership Award, NCPA Preceptor of the Year and most recently being named UF College of Pharmacy Outstanding Alumnus in 2019. She and her husband Joe are active in their church, First Baptist of Melbourne, as 1st grade Sunday School teachers and they have 3 children, Taryn, a graduating UF Vet School student, TJ, a recent UCF alum and Taelyn a high school junior.

Accommodations

ROOM RATES: $195 plus tax based on single/double occupancy. The room reservation deadline is Friday, June 17, 2022 or when room block is full. Thereafter, reservations may be taken on a space available or rate available basis. There is an optional resort fee. Self-parking is discounted to $12 per day. Please be sure to ask for the Florida Pharmacy Association group rate. All reservations must be accompanied by a first night room deposit guaranteed with a major credit card. The check-in time is 4:00 p.m. and the checkout time is 11:00 a.m.

Convention Special Events

House of Delegates: Be a delegate or observer and see how important member participation is to the direction of the Association. FPPC Reception: Attend this reception to support your Political Action Committee. President’s 250 Club: Contribute to the FPPC and be invited to a private reception. Exhibits: Participate in the grand opening reception in the exhibit hall! Visit with exhibitors, introduce yourself, tell them you appreciate them and invite them back next year! The exhibitors are a very important part of FPA’s convention. Companies send their representatives to educate you about their products and services at great expense. Please show them your appreciation! Poster Presentations: Browse submissions from all pharmacy professionals. Contact the FPA office for more information if you would like to submit a poster presentation. Receptions: Enjoy catching up with your colleagues as the Universities entertain their alumni and friends! Foundation Celebration Event: Recognize 2022 Foundation Donors and Student Award Recipients. Student Events: Participate in the Student-Pharmacist Mentor Social. Students will benefit from interacting with practicing pharmacists, attending student focused continuing education programs and learning firsthand about the FPA and how involvement can improve their chosen profession. Call the FPA office and offer to mentor or sponsor a student. Awards Event: Honor outstanding practitioners during the awards presentation. Installation of Officers: Attend the installation of NEW officers on Sunday morning!

CONTINUING EDUCATION CODE KEY:

FLORIDA PHARMACY TODAY

GCE = General

RC = Recertification Consultant

TECH = Technician

STU = Student

Wednesday, July 6 7:30am-5:00pm 2:00pm-4:00pm 4:00pm-5:00pm 5:00pm-6:00pm 6:00pm-7:00pm 7:30pm

Pharmacy Based Point-of-Care Test & Treat Certificate Program FPA Registration Desk Opens HOD Board of Directors Meeting Florida Pharmacist Political Committee (FPPC) Meeting Budget & Finance Committee Meeting Florida Pharmacy Association Officer’s Meeting

Thursday, July 7 5 hrs of GCE/TECH 7:00am 7:30am 7:45am-9:15am

Legislative Update 2022

Registration Desk Opens Welcome and Introductions Education: 1.5 hrs GCE/TECH

Michael Jackson, BPharm, CPh, Executive Vice President and CEO, Florida Pharmacy Association (RETIRED) Upon completion of this activity, pharmacists will be able to: Describe the recent and proposed changes to Florida laws related to the practice of pharmacy; Execute changes within the pharmacy to maintain compliance with current Florida laws; Explain how revisions to the pharmacy practice act and rules may help technicians in their efforts to support pharmacist services. UAN: 0165-0000-22-024-L03-P Upon completion of this activity, technicians will be able to: Recognize the recent and proposed changes to Florida laws related to the practice of pharmacy; Identify changes within the pharmacy to maintain compliance with current Florida laws; Explain how revisions to the pharmacy practice act and rules may help technicians in their efforts to support pharmacist services. UAN: 0165-0000-22-024-L03-T 8:00am-10:00am Delegate Registration 9:20am-10:50am Education: 1.5 hrs GCE/TECH New Drug Update 2021-2022 Olga Wydner, ASN, PharmD, Pharmacy Manager, Publix, Clinical Affiliate Assistant Professor, NOVA Southeastern University College of Pharmacy. Upon completion of this activity, pharmacists will be able to: Review the FDA process for approving new drugs; List some of the therapeutic agents approved for use in 2021-2022; Describe the pharmacology, adverse effects, drug interactions, therapeutic uses and dosing of selected prescription drugs recently marketed; Examine the role of currently marketed and emerging therapeutics in the prevention/management of COVID-19. UAN: 0165-0000-22-025-L01-P Upon completion of this activity, technicians will be able to: Recognize new drugs to be released; Identify indications of newly released drugs; List the emerging agents in the prevention and management of COVID-19. UAN: 0165-0000-22-025-L01-T 11:00am-1:00pm

FPA House of Delegates and Annual Business Meeting

12:00pm-1:00pm

Lunch Break

1:00pm-2:00pm

Education: 1 hr GCE/TECH

Pharmacy Burn Out and Wellness

Samantha Thompson, PharmD, CPh, Assistant Professor of Pharmacy, Florida A&M University | College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Northeast Florida Pharmacy Practice Center Upon completion of this activity, participants will be able to: Describe what occupational burnout is and the background associated with burnout; Review how to recognize the signs of occupational burnout; Review Florida pharmacist burnout data during COVID-19; List helpful skills to promote self-care and wellness; Discuss resilience skills and tools to increase tenacity. UAN: 0165-0000-22-026-L04-P Upon completion of this activity, technicians will be able to: Identify what occupational burnout is and the background associated with burnout; Recognize the signs occupational burnout; Review Florida pharmacist burnout data during COVID-19; Identify helpful skills to promote self-care and wellness; Discuss resilience skills and tools to increase tenacity. UAN: 0165-0000-22-026-L04-T 2:05pm-3:05pm

Education: 1 hr GCE/TECH/STU

Keynote Address: Today Is The Day! Finding the Treasures Within the Profession of Pharmacy Theresa Wells Tolle, BPharm, FAPhA, Owner, Bay Street Pharmacy, Inc.

Upon completion of this activity, pharmacists will be able to: Describe the current environment in pharmacy today and historical barriers that have limited pharmacists ability to maximize patient care opportunities; Discuss emerging clinical roles for pharmacists within Florida; Name some regulatory or legislative actions that need to take place to allow pharmacists and pharmacy teams to fully display their untapped treasures; Advocate efforts to further the role of the pharmacist to improve the lives of patients, the health of communities and well-being of pharmacy teams. UAN: 0165-0000-22-042-L04-P Upon completion of this activity, technicians will be able to: Describe the current environment in pharmacy today and historical barriers that have limited pharmacists ability to maximize patient care opportunities; Identify regulatory or legislative actions that need to take place to allow pharmacists and pharmacy teams to fully display their untapped treasures; Advocate efforts to improve the lives of patients, the health of communities and well-being of pharmacy teams. UAN: 0165-0000-22-042-L04-T 3:30pm-5:30pm 5:30pm-6:30pm 7:00pm

House of Delegates Reconvenes FPPC Reception President’s 250 Club

JUNE 2022

Friday July 8 6 hrs GCE/TECH/RC 7:00am

Registration Desk Opens

7:45am-9:15am

Education: 1.5 hrs GCE/TECH/RC

SARS-CoV-2: The Virus’ Characteristics - The Treatment and Vaccines - The Impacts on Communities

Kevin B. Sneed, PharmD, FNAP, FNPHA, Senior Associate Vice-President, USF Health, Dean and Professor, USF Health Taneja College of Pharmacy, University of South Florida Upon completion of this activity, pharmacists will be able to: Review the history and characteristics of the SARS-CoV-2 virus; Discuss the human pathophysiology associated with SARS-Cov-2; Discuss the vaccine therapeutics designed to protect against SARS-CoV-2 infection, including vaccine development; Review the clinical impact of SARS-CoV-2, including long-term clinical challenges; Discuss the health inequities associated with SARS-CoV-2 in communities across the USA. UAN: 0165-0000-22-027-L01-P Upon completion of this activity, technicians will be able to: Define SARS-CoV-2 virus; Review the Coronaviridae virus and discuss factors and disease progression; Identify potential prevention and treatment options for SARS-CoV-2 virus. UAN: 0165-0000-22-027-L01-T 9:00am-11:00am

Journal Board Meeting

9:00am-11:00am

Education: 2 hrs STU (Non CE)

Pharmacy Career Forum

Theresa Tolle, BPharm, FAPhA, Owner, Bay Street Pharmacy, Inc. - Facilitator Upon completion of this activity, students will be able to: Recognize various practices of pharmacy and opportunities available to pharmacists and technicians; Describe the practice setting that best suit the individual skills and abilities; Identify personal strengths and weaknesses to consider when contemplating career choices. 9:20am-10:50am

Education: 1.5 hrs GCE/TECH/RC

Pivot! The Evolving Role of the Pharmacy Team Amidst the COVID-19 Pandemic

Laura A. Rhodes, PharmD, BCACP, Assistant Professor of Pharmacy Practice, Director, Enhanced Community Pharmacy Services Fellowship Consultant, Enhanced Community Pharmacy Services and Erin Dorval, PharmD, Director, Community-based Pharmacy Upon completion of this activity, pharmacists will be able to: Discuss legal or regulatory considerations related to enhanced pharmacy services for COVID-19, such as immunization, point-of-care testing, and distribution of therapeutics; Discuss the current and emerging role of pharmacists in the provision of enhanced pharmacy services for COVID-19, such as immunization, point-of-care testing, and distribution of therapeutics; Identify resources to stay up-to-date on enhanced pharmacy services. UAN: 0165-0000-22-028-L01-P Upon completion of this activity, technicians will be able to: Discuss legal or regulatory considerations related to enhanced pharmacy services for COVID-19, such as immunization, point-of-care testing, and distribution of therapeutics; Discuss the current and emerging role of the pharmacy technician in the provision of enhanced pharmacy services for COVID-19, such as immunization, point-of-care testing, and distribution of therapeutics; Identify resources to stay up-to-date on enhanced pharmacy services. UAN: 0165-0000-22-028-L01-T 11:00am-1:00pm

Exhibit Hall Grand Opening

11:00am-1:00pm

Poster Presentations

12:00pm-1:00pm

Lunch Break

1:00pm-2:30pm

Local Unit Leaders Meeting

1:00pm-2:30pm

Education: 1.5 hrs GCE/TECH/RC

How Low Should BP Go? The Current Landscape of Hypertension

Genevieve Hale, PharmD, BCPS, Palm Beach Gardens Campus Vice Chair, Assistant Professor, Department of Pharmacy Practice, Clinical Pharmacy Specialist - Cardiology, Nova Southeastern University College of Pharmacy Upon completion of this activity, pharmacists will be able to: Describe treatment recommendations in current hypertension guidelines; Explain the similarities and differences between past and new hypertension guidelines; Apply current guidelines to the management of patients with hypertension; Discuss the impact of COVID on cardiovascular disease. UAN: 0165-0000-22-029-L01-P Upon completion of this activity, technicians will be able to: Review information regarding the impact of hypertension on patients; List blood pressure lowering therapy options available for the management of hypertension; Describe strategies to improve knowledge and awareness regarding goals for blood pressure therapy. UAN: 0165-0000-22-029-L01-T 1:00pm-2:30pm

NASPA/NMA Game Show

Education: 1.5 hrs GCE/TECH/STU

Tian Merren Owens, MS, PharmD, Director of Continuing Education, Florida Pharmacy Association - Facilitator Upon completion of this activity, pharmacists will be able to: Identify and explain aspects of the effective and safe practice of pharmacy self-care treatments; Analyze the usage and effectiveness of over the counter medications; Classify different groups of over the counter medications based on drug treatment class. UAN: 0165-0000-22-030-L01-P Upon completion of this activity, technicians will be able to: Identify the use of over-the-counter medications; List the classes of various OTC products; Identify proper storage and handling techniques of OTC products. UAN: 0165-0000-22-030-L01-T 2:35pm-4:05pm

Education: 1.5 hrs GCE/TECH/RC

Putting the Success in Heart Failure Management: A Case Based Series

Michelle Pike, Pharm.D., BCCP, Clinical Pharmacy Practitioner (Cardiology) at Bay Pines Veterans Affairs Medical Center Upon completion of this activity, pharmacists will be able to: Describe the importance of medication titration heart failure with reduced ejection fraction; Recognize potential treatment options for patients with heart failure without reduced ejection fraction; Effectively counsel patients on new therapies for heart failure; Identify common high risk medications in heart failure. UAN: 0165-0000-22-031-L01-P Upon completion of this activity, technicians will be able to: Define heart failure and ejection fraction; Recognize the importance of medication titrations in heart failure; Identify new therapies used for heart failure. UAN: 0165-0000-22-031-L01-T

2:35pm

Patient Counseling Competition

5:00pm-6:30pm

University Alumni Receptions

6:30pm-7:30pm

Student and Mentor Social

7:30pm

Foundation Celebration Event

FLORIDA PHARMACY TODAY

Saturday July 9 6 hrs of GCE/TECH/RC 6:45am-7:45am 6:45am-7:45am

7:00am 7:45am-8:45am

Diabetes Through the Life Span

Genentech Breakfast Florida Independent Pharmacy Owner Breakfast RSVP 850-656-0100 Registration Desk Opens Education 1 hr GCE/TECH/RC

Marile Santamarina, MS, PharmD, CPh, CDE, CPT, Medical Science Liaison, Amarin Field Medical Upon completion of this activity, pharmacists will be able to: Review challenges associated with the management of diabetes; Discuss diabetes challenges in toddlers and children; adolescents and young adults; and adulthood; Describe glycemic control measures for each lifespan. UAN: 0165-0000-22-032-L01-P Upon completion of this activity, technicians will be able to: Define diabetes; Discuss diabetes challenges in toddlers and children, adolescents and young adults; and adulthood; Identify glycemic control measures for each lifespan. UAN: 0165-0000-22-032-L01-T 8:50am-9:50am

Education 1 hr GCE/TECH/RC

The Role of Glucagon-like Peptide -1 Receptor Agonist in the Management of Type 2 Diabetes Mellitus

Marile Santamarina, MS, PharmD, CPh, CDE, CPT, Medical Science Liaison, Amarin Field Medical Upon completion of this activity, pharmacists will be able to: Overview of pathophysiology of type 2 diabetes mellitus; Discuss Glucagon-like Peptide-1 receptor agonist as a drug class; Evaluate antiglycemic and cardiovascular outcomes trial data of GLP-1 RA in the management of type 2 diabetes mellitus; Analyze and make clinical recommendations in patient practice cases. UAN: 0165-0000-22-033-L01-P* Upon completion of this activity, technicians will be able to: Write the brand and generic names of GLP-1 RA; List the side effects of GLP-1 RA drug class in the management of type 2 diabetes mellitus; Choose a Patient Assistance Programs (PAP) for GLP-1 RA to help offset patient’s financial burden. UAN: 0165-0000-22-033-L01-T* 9:00am-11:00am

Making a Good First Impression: A CV and Interview Primer

Education: 2 hrs STU (Non CE)

Jennifer Pytlarz, PharmD, BCACP, Evolent Health, Managing Director, Clinical Pharmacy Services, Residency Program Director Upon completion of this activity, students will be able to: Explain the difference between a resume and a curriculum vitae (CV) and when to use each; Describe how to build a CV; Discuss how to prepare for and conduct yourself during an interview; Review the interview process; Practice mock interviews 9:55am-10:55am

SGLT2 Inhibitors: More Than Just for Glycemic Control

Education 1 hr GCE/TECH/RC

Jordan Sedlacek, PharmD, BCACP, BC-ADM, Assistant Professor and PGY2 Ambulatory Care Residency Program Director at Lloyd L. Gregory School of Pharmacy at Palm Beach Atlantic University Upon completion of this activity, pharmacists will be able to: Explain the mechanism of action of SGLT-2 inhibitors; Discuss the cardiovascular benefit of SGLT-2 inhibitors; Discuss the renal benefit of SGLT-2 inhibitors; Given a patient case, create the most appropriate plan. UAN: 0165-0000-22-034-L01-P* Upon completion of this activity, technicians will be able to: Match the SGLT2 inhibitor brand and generic names; List the possible benefits of SGLT2 inhibitors; Describe the possible side effects of SGLT2 inhibitors; Choose patient assistance programs for SGLT2 inhibitors. UAN: 0165-0000-22-034-L01-T* 11:00am-1:00pm Exhibit Hall Opens 12:00pm-1:00pm Lunch Break 1:00pm-2:00pm Education: 1 hr GCE/TECH/RC

Increasing Technology Literacy: Continuous Glucose Monitors

Angelina Vascimini, PharmD, Assistant Professor Department of Pharmacotherapeutics and Clinical Research, University of South Florida Taneja College of Pharmacy. Upon completion pharmacists will be able to: Cite evidence supporting Continuous Glucose Monitors (CGM) use in diabetes care; Discuss patient and clinician education resources; Plan how to optimally use CGM while creating awareness for common barriers to patient utilization; Integrate CPT codes for CGM training and CGM data interpretation in patient care models. UAN: 0165-0000-22-035-L01-P* Upon completion technicians will be able to: Recognize the importance of Continuous Glucose Monitors (CGM) use in diabetes care; Name educational resources for CGMs; Recognize the barriers for patients using CGMs; Use CPT codes for diabetes billing. UAN: 0165-0000-22-035-L01-T* 2:05pm-3:05pm Education 1 hr GCE/TECH/RC

Overview of Insulin Pumps, CGM and Time & Range

Marile Santamarina, MS, PharmD, CPh, CDE, CPT, Medical Science Liaison, Amarin Field Medical and Angelina Vascimini, PharmD, Assistant Professor Department of Pharmacotherapeutics and Clinical Research, University of South Florida Taneja College of Pharmacy Upon completion of this activity, pharmacists will be able to: Discuss advantages and disadvantages of various insulin pumps; Review how to use insulin pumps and continuous glucose monitors (CGM) to improve glycemic control; Analyze “Time in Range” (TIR) as a new measure of glycemic control; Given a patient case, apply insulin pump and continuous glucose monitors knowledge to patient cases. UAN: 0165-0000-22-036-L01-P* Upon completion of this activity, technicians will be able to: Recognize how insulin pumps are used in diabetes care; List advantages and disadvantages of insulin pumps; Describe Time and Range and its importance in glycemic control. UAN: 0165-0000-22-037-L01-T 3:10pm-4:10pm Education 1 hr GCE/TECH/RC

Telephoning Sweet Financial Success: A Discussion of Sustainable Billing Models

Angelina Vascimini, PharmD, Assistant Professor Department of Pharmacotherapeutics and Clinical Research, University of South Florida Taneja College of Pharmacy. Upon completion of this activity, pharmacists will be able to: Discuss CMS recognized billable codes permitted during diabetes care visits with required documentation;

CONTINUING EDUCATION CODE KEY:

GCE = General

RC = Recertification Consultant

TECH = Technician

STU = Student

JUNE 2022

Discuss chronic care management (CCM) service literature and the role of ambulatory pharmacists; Design a CCM service with inclusion of required CMS components for enrollment, documentation, and reimbursement; Assemble a practice model using recognized billable codes with extension into value based evaluations. UAN: 0165-0000-22-038-L01-P * Upon completion of this activity, technicians will be able to: Identify which diseases are listed under chronic care management (CCM); Explain the components for enrollment, documentation, and reimbursement; Use correct codes for diabetic supplies; Use billable codes for patient reimbursements. UAN: 0165-0000-22-038-L01-T* 5:00pm-6:00pm

Past Presidents Reception (Invitation Only)

7:00pm

Awards Banquet (Professional Attire)

Sunday July 10 5 hrs of GCE/TECH 6:45am-7:45am

Sunday Morning Worship

7:00am

Registration Desk Opens

7:45am-9:45am

Education: 2 hrs GCE/TECH

Reducing Medication Errors through Implementing a Continuous Quality Improvement

Michael Jackson, BPharm, CPh, Executive Vice President and CEO, Florida Pharmacy Association (RETIRED) Upon completion of this activity, pharmacists will be able to: Define elements of a Continuous Quality Improvement (CQI) Program; Restructure a pharmacy practice to address quality related events; Discuss how to use Root Cause Analysis (RCA) to prevent errors; Implement an action plan to address quality of care in pharmacies with a goal towards error reduction and prevention; Recite quality improvement regulations for Florida pharmacies; Implement programs to improve patient safety in pharmacy health care systems. UAN: 0165-0000-22-039-L05-P Upon completion of this activity, technicians will be able to: Define CQI; Discuss RCA; List most common medication errors; Employ techniques to reduce medication errors by using CQI. UAN: 0165-0000-22-039-L05-T 9:50am-10:50am

HIV/AIDS Update 2022

Education: 1 hr GCE/TECH

Elizabeth Sherman, PharmD, AAHIVP, Associate Professor, Nova Southeastern University College of Pharmacy. Upon completion of this activity, pharmacists will be able to: Review modes of HIV transmission; Identify higher risk behaviors; Interpret current Florida law on HIV/AIDS; Discuss the pharmacist’s role in providing care for patients with HIV; Describe the mechanism of action of antiretrovirals; Describe the rationale behind combination therapies. UAN: 0165-0000-22-040-L02-P Upon completion technicians will be able to: Define HIV and AIDS; List methods of HIV transmission; Identify higher risk behaviors; Recognize current Florida law on HIV/AIDS. UAN: 0165-0000-22-040-L02-T 10:55am-11:15am

Installation of Officers

11:15am-11:25am

Break

11:25am-1:25pm

Education: 2 hrs GCE/TECH

Validation and Counseling of Prescriptions for Controlled Substance and Opioids

Bob Parrado, BPharm, CPh, President and CEO, Parrado Pharmacy Consultants, Inc. Upon completion of this activity, participants will be able to: Describe how to ensure access to controlled substances for all patients with a valid prescription; Use the Prescription Drug Monitoring Program’s Database; Assess prescriptions for appropriate therapeutic value; Detect prescriptions that are not based on a legitimate medical purpose; Discuss the laws and rules related to the prescribing and dispensing of controlled substances; Discuss proper patient storage and disposal of controlled substances; Discuss protocols for addressing and resolving problems recognized during the drug utilization review; Provide education on section 381.887, F.S., emergency treatment for suspected opioid overdoses and on the State Surgeon General’s Statewide Standing Order for Naloxone; Counsel patients with opioid prescriptions; and Provide available treatment resources for opioid physical dependence, addiction, misuse, or abuse. UAN: 0165-0000-22-041-L03-P* Upon completion technicians will be able to: Use the Prescription Drug Monitoring Program’s \Database; Assess prescriptions for appropriate and accurate information; Recognize the laws and rules related to the prescribing and dispensing of controlled substances. UAN: 0165-0000-22-041-L03-T*

*Wednesday Pre-Convention Education

The Pharmacy Based Point-of-Care Test and Treat Certificate Program provides an opportunity to gain the skills and information necessary to develop a test and treat program for minor, nonchronic health conditions, such as influenza, Group A Streptococcus, and minor, uncomplicated infections, within the framework of an established written protocol with a supervising physician. The target audience for the certificate program is pharmacists with the skills necessary to develop a testing and treatment program for minor, nonchronic health conditions, such as influenza, Group A streptococcus, and minor, uncomplicated infections The 20-hour certificate program includes comprehensive material regarding key disease states, physical assessment, point-of-care tests, collaborative practice models, and business models through: • 12 hours of home study • 8 hours of live training I CO N S & S O C I A L M E D I A LO G O S F O R B U S I N E Participants take an online assessment after each of the 7 modules of the home study. In addition, there will be a cumulative assessment (must pass 70% within three attempts). Proficiency to conduct screenings, physical assessments and offer point-of-care test and treat services will be assessed in the live training. Upon successful completion of both portions of the program and all program evaluations, participants are awarded a certificate of C O N (CPE) S & credit. S OThis C Iactivity A L isM E D I A LO G O S F O R B U S I N E S S C completion and pharmacists will receive 20 hours of Continuing PharmacyIEducation a certificate program for pharmacists. The release date is 9/1/2021. The expiration date is 9/1/2024. There are a total of 20 contact hours (2.0 CEUs). UAN 0165-9999-21-066-B01-P. Visit www.floridapharmacy.org for a complete list of learning objectives, faculty credentials and detailed information. I CO N S

S O C I A L

The Florida Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 20 contact hours are available upon successful completion of both portions of the certificate program on Wednesday. Certificate of continuing pharmacy education credit will be available for you to download and print immediately. Up to 22 contact hours are available upon successful completion of attendance and evaluation from Thursday-Sunday. Statements of continuing pharmacy education credit will available for you to download and print in four weeks. The FPA is also a Florida Department of Health approved provider of continuing education. This is an ACPE application* and knowledge based activity. Speakers have no relevant financial relationship to the activities.

M E D I A

LO G O S

F O R

B U S I N E S S

CA R D

Conference Information

Target Audience: FPA’s educational activities are designed for pharmacists and pharmacy technicians from all practice settings. • Courses appropriate for pharmacists are designated by an ACPE UAN ending in the letter “P”. • Courses appropriate for pharmacy technicians are designated by an ACPE UAN ending in the letter “T”. Contact Hours: Florida Pharmacy Association is offering up to 22 contact hours during Convention. Each course identifies the amount of credit which can be received. A total of 22 contact hours may be obtained from Thursday through Sunday for General (GCE) or Technician (TECH) continuing education. Reducing Medication Errors, HIV/AIDS, and the Validation and Counseling of Prescriptions for Controlled Substances are Florida board approved courses. Twelve of the offered 22 hours may be used for Consultant Re-certification (RC). Please see the paragraph below for further information regarding Consultant Recertification. Consultant Re-certification: To receive consultant re-certification credit for your Florida consultant pharmacist license, you must complete a minimum of 3 hour blocks courses marked RC for partial credit. The RC courses are offered on Friday and Saturday. There are 6 RC hours on Friday and 6 RC hours on Saturday. Florida Board of Pharmacy Consultant Approval Number is pending. Disclosures: Financial support has not been provided for any educational activities. All event sponsors will be listed in program. Speakers have no relevant financial relationship to the activities. Handouts: Printed booklets of the handouts are available for purchase. Handouts will be posted on our website, www.floridapharmacy.org, the week of the conference for you to download, print and bring to the meeting. CPE Requirements: To earn a statement of credit, participants must complete the necessary information, which includes name, license number, NABP number, date of birth, and evaluation on the survey. Statements of credit will be available for you to download and print four weeks following the meeting. • CE Broker: FPA will upload courses to CE Broker, the continuing education system for the Florida Department of Health. It is the responsibility of the participant to provide the correct pharmacist license number or pharmacy technician registration number. CE Broker offers a reduced subscription rate to FPA members per license cycle. • CPE Monitor: FPA will upload courses to CPE Monitor, which allows you to electronically keep track of CPE credits from ACPE-accredited providers. Visit www. mycpemonitor.net to obtain your e-profile. It is the responsibility of the participant to provide the correct e-profile number and date of birth (MM/DD) prior to the upload. FPA will NOT re-upload data once upload is complete.

Local Attractions Bonnet House Museum & Gardens Old Dillard Museum Intercoastal Waterway Everglades Safari Park FatVillage Arts District Riverfront Ft. Lauderdale Museum of Discovery & Science & Autonation IMAX Sawgrass Mills Outlets Galleria Mall Las Olas Boulevard

Cancellation Policy: If cancellation is made in writing 30 days prior to the program a refund will be made less a $10 service charge. If cancellation is made 29-10 days prior to the program, a refund will be made, less a $50 service charge. Cancellation requested in writing after that date will result in credit for another FPA CE program valid for one year. Partial Credit Policy: FPA does not offer partial credit for any CPE activity. Participants must attend the session in its entirety. Temperature: Please have a sweater or jacket available during the meetings as temperature may vary. Children: Children under the age of 18 are not permitted in the educational programs at anytime due to insurance liability issues. This includes children in strollers and carriers. ADA Regulations: The FPA complies with ADA requirements. Please contact the office in advance of the meeting for any needed technical assistance. FPA Policy on Industry Support: FPA adheres to the US Food & Drug Administration’s policy on industry supported educational activities. The FDA policy requires, among other things, that we conduct the educational program supported by any corporate educational grants independently and without control by the grantor of the program’s planning, content or execution. Furthermore, the programs must be free of commercial bias for or against any product. Waiver of Liability: Each individual attending FPA’s Annual Meeting assumes all risks associated with his/her attendance and participation in all on-and off-site activities that occur during this time. By registering for this meeting, you agree to indemnify and hold harmless, FPA and its governing bodies, officers and employees from all loss, damage or liability arising out of or related to your attendance and participation at FPA’s Annual Meeting. COVID Waiver: It is our desire to bring to you an outstanding convention and educational experience while helping everyone to stay safe during this current pandemic. If you, or a member of your party, have traveled to areas where COVID-19 is spreading, or you have been in contact with individuals who have COVID immediately prior to the convention, we ask that you not participate in this event. By registering for and attending the FPA’s Annual Meeting and Convention, you are acknowledging that an inherent risk of exposure to COVID-19 exists in any public place where people are present. By attending the Annual Meeting and Convention, you and any guests voluntarily assume all risks related to exposure to COVID-19 and agree not to hold the Florida Pharmacy Association and its related event organizers liable for any illness or injury. Participants must agree to the above disclaimer along with following local health guidelines in order to participate at the FPA Annual Meeting and Convention. If you are showing symptoms of possible COVID-19, we will be unable to admit you to the meeting.

Thank you for attending the 132nd Annual Meeting & Convention! See you next year!

Save the Date! 133rd Annual Convention

JW Marriott Marco Island Beach Resort Marco Island, FL

July 5 – 9, 2023 JUNE 2022

Who Should Attend? Community Pharmacists Consultant Pharmacists Hospital Pharmacists Long Term Care Pharmacists Managed Care Pharmacists Pharmacy Owners Pharmacy Students Pharmacy Technicians

132nd Annual Meeting and Convention Schedule July 6 – 10, 2022

Marriott Harbor Beach Resort & Spa 3030 Holiday Drive • Ft. Lauderdale, FL (800) 222-6543 or (954) 525-4000 Room Rate: $195 and up by June 17, 2022 (or once room block full) After this date, reservations are taken on a space or rate available basis.

Protect your patients. Protect your pharmacy. ERRORS CA N IN JURE PATIENTS A N D PUT YOUR PHARMACY IN F I NANCIAL JEO PARDY.

The PQC+ QA program can improve efficiency and increase patient safety as well as help you meet accreditation, credentialing, PBM and state Quality Assurance requirements. • Training, Quality Assurance CE, and resources • Patient Safety Organization protection for your QA work • Practical tools to collect and analyze patient safety data

Learn more at www.medicationsafety.org or call us at (866) 365-7472. The Alliance of Medication Safety (APMS) is a federally listed Patient Safety Organization (PSO). J U N E 2 0 2 2 | 19

“I’M ALWAYS WATCHING OUT FOR MY PATIENTS, BUT WHO’S WATCHING OUT FOR ME?”

WE ARE. We are the Alliance for Patient Medication Safety (APMS), a federally listed Patient Safety Organization. Our Pharmacy Quality Commitment (PQC) program: • • • •

Helps you implement and maintain a continuous quality improvement program Offers federal protection for your patient safety data and your quality improvement work Assists with quality assurance requirements found in network contracts, Medicare Part D, and state regulations Provides tools, training and support to keep your pharmacy running efficiently and your patients safe

Call toll free (866) 365-7472 or visit www.pqc.net PQC IS BROUGHT TO YOU BY YOUR STATE PHARMACY ASSOCIATION